Tag: athenex
November 14, 2018
Athenex Announces Third Quarter 2018 Financial Results and Provides Corporate Update
Athenex (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of... October 29, 2018
Athenex Announces FDA Allowance of Investigational New Drug Application of Eribulin ORA to Begin Clinical Trials
Athenex (Nasdaq:ATNX) a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of... August 9, 2018
Athenex Pharmaceutical Division Receives FDA Clearance to Import Potassium Chloride Injection Concentrate to Address U.S. Drug Shortage
Athenex (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of... July 18, 2018
